{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:18:02Z","timestamp":1790309882474,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002977","name":"Dalhousie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005785","name":"Dalhousie University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.autrev.2023.103485","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:07:47Z","timestamp":1701328067000},"page":"103485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications"],"prefix":"10.1016","volume":"23","author":[{"given":"Roopa","family":"Hebbandi Nanjundappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channakeshava","family":"Sokke Umeshappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0010","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOG.0b013e3280b079fb","article-title":"Cholangiocyte biology","volume":"23","author":"Bogert","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5009\/gnl16033","article-title":"Biology of cholangiocytes: from bench to bedside","volume":"10","author":"Yoo","year":"2016","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0035","first-page":"925","article-title":"Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree","volume":"40","author":"Harada","year":"2004","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2023.103485_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0168-8278(92)90028-N","article-title":"Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis. An immunohistochemical study","volume":"15","author":"Saito","year":"1992","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0045","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","article-title":"Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium","volume":"136","author":"D\u2019Aldebert","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jcmgh.2020.02.002","article-title":"Swimming against the current: MAIT cell function is preserved in the peritoneum of advanced liver disease patients","volume":"9","author":"Hackstein","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0055","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2017.09.016","article-title":"iNKT cells orchestrate a switch from inflammation to resolution of sterile liver injury","volume":"47","author":"Liew","year":"2017","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0060","doi-asserted-by":"crossref","first-page":"G244","DOI":"10.1152\/ajpgi.00366.2013","article-title":"Inhibition of toll-like receptor 4 suppresses liver injury induced by biliary obstruction and subsequent intraportal lipopolysaccharide injection","volume":"306","author":"Oya","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/labinvest.3700556","article-title":"Interaction of toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture","volume":"87","author":"Ikeda","year":"2007","journal-title":"Lab Invest"},{"issue":"8","key":"10.1016\/j.autrev.2023.103485_bb0070","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2008.01921.x","article-title":"Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia","volume":"29","author":"Barnes","year":"2009","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O\u2019Hara","year":"2013","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00428-011-1048-3","article-title":"Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered","volume":"458","author":"Desmet","year":"2011","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00281-009-0167-2","article-title":"Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"31","author":"Borchers","year":"2009","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.31311","article-title":"The role of the intestine in the pathogenesis of primary sclerosing cholangitis: evidence and therapeutic implications","volume":"72","author":"Dean","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"10266","key":"10.1016\/j.autrev.2023.103485_bb0100","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI200110716","article-title":"Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis","volume":"108","author":"Odin","year":"2001","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2023.103485_bb0115","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3389\/fimmu.2019.02633","article-title":"Constitutive activation of natural killer cells in primary biliary cholangitis","volume":"10","author":"Hydes","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0120","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41385-018-0066-8","article-title":"Natural killer T cells mediate inflammation in the bile ducts","volume":"11","author":"Berntsen","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-018-0034-2","article-title":"Tissue-specific functions of invariant natural killer T cells","volume":"18","author":"Crosby","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nri2743","article-title":"iNKT cell autoreactivity: what is \u2018self\u2019 and how is it recognized?","volume":"10","author":"Gapin","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/imm.12481","article-title":"Invariant natural killer T cells and their ligands: focus on multiple sclerosis","volume":"145","author":"O\u2019Keeffe","year":"2015","journal-title":"Immunology"},{"issue":"9777","key":"10.1016\/j.autrev.2023.103485_bb0140","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0150","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2008.05.003","article-title":"CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis","volume":"31","author":"Shimoda","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103485_bb0160","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.cgh.2023.04.004","article-title":"Recent advances in the management of primary sclerosing cholangitis","volume":"21","author":"Assis","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.autrev.2023.103485_bb0170","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103485_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fimmu.2015.00255","article-title":"Regulation of NKT cell localization in homeostasis and infection","volume":"6","author":"Slauenwhite","year":"2015","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.autrev.2023.103485_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205174","article-title":"The current landscape of NKT cell immunotherapy and the hills ahead","volume":"13","author":"Nelson","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what\u2019s in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-immunol-032713-120243","article-title":"Biology of CD1- and MR1-restricted T cells","volume":"32","author":"Salio","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0195","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fimmu.2018.01393","article-title":"Invariant natural killer T cell subsets-more than just developmental intermediates","volume":"9","author":"Krovi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0200","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fimmu.2018.01969","article-title":"Type II NKT cells: an elusive population with immunoregulatory properties","volume":"9","author":"Singh","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2015.00316","article-title":"Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer","volume":"6","author":"Marrero","year":"2015","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103485_bb0210","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1084\/jem.20011544","article-title":"A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(\u2212)CD4(+) CD1d-dependent precursor stage","volume":"195","author":"Pellicci","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.autrev.2023.103485_bb0215","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/intimm\/10.10.1491","article-title":"Three day neonatal thymectomy selectively depletes NK1.1+ T cells","volume":"10","author":"Hammond","year":"1998","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ni.3668","article-title":"Alternative pathway for the development of Valpha14(+) NKT cells directly from CD4(\u2212)CD8(\u2212) thymocytes that bypasses the CD4(+)CD8(+) stage","volume":"18","author":"Dashtsoodol","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0225","first-page":"7","article-title":"CCR7 defines a precursor for murine iNKT cells in thymus and periphery","author":"Wang","year":"2018","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0230","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.182.6.2091","article-title":"Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes","volume":"182","author":"Bendelac","year":"1995","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0235","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.1641","article-title":"The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions","volume":"9","author":"Kovalovsky","year":"2008","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","article-title":"The transcription factor PLZF directs the effector program of the NKT cell lineage","volume":"29","author":"Savage","year":"2008","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.autrev.2023.103485_bb0245","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ni.2731","article-title":"Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells","volume":"14","author":"Lee","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0255","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3389\/fimmu.2018.01450","article-title":"How lipid-specific T cells become effectors: the differentiation of iNKT subsets","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0260","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.3437","article-title":"Innate-like functions of natural killer T cell subsets result from highly divergent gene programs","volume":"17","author":"Engel","year":"2016","journal-title":"Nat Immunol"},{"issue":"6855","key":"10.1016\/j.autrev.2023.103485_bb0265","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"issue":"50","key":"10.1016\/j.autrev.2023.103485_bb0270","doi-asserted-by":"crossref","first-page":"19845","DOI":"10.1073\/pnas.0806472105","article-title":"Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation","volume":"105","author":"Michel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0275","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.0901059","article-title":"Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions","volume":"183","author":"Doisne","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0280","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1172\/JCI72308","article-title":"IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset","volume":"124","author":"Sag","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ni.3047","article-title":"Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue","volume":"16","author":"Lynch","year":"2015","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0290","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.4049\/jimmunol.1000359","article-title":"Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta","volume":"185","author":"Monteiro","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ni.2172","article-title":"Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner","volume":"13","author":"King","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ni.2166","article-title":"Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses","volume":"13","author":"Chang","year":"2011","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0305","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.autrev.2011.06.003","article-title":"Role of NKT cells in autoimmune liver disease","volume":"10","author":"Santodomingo-Garzon","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030517","article-title":"Genetic analysis of multiple myeloma identifies cytogenetic alterations implicated in disease complexity and progression","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0315","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0320","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ni1002","article-title":"Mechanism of CD1d-restricted natural killer T cell activation during microbial infection","volume":"4","author":"Brigl","year":"2003","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0325","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nm0602-588","article-title":"CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung","volume":"8","author":"Nieuwenhuis","year":"2002","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0330","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1053\/jhep.2003.50471","article-title":"Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo","volume":"38","author":"Ito","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0335","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease","volume":"51","author":"Syn","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/MEG.0b013e32831bc3d6","article-title":"Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease","volume":"21","author":"Tajiri","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2008.10.027","article-title":"Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage","volume":"136","author":"Wintermeyer","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0355","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13117","article-title":"The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation","volume":"5","author":"Schrumpf","year":"2017","journal-title":"Physiol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0360","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0365","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/gast.2002.36020","article-title":"Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer","volume":"123","author":"Kita","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0370","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.autrev.2023.103485_bb0375","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.191.1.105","article-title":"Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis","volume":"191","author":"Kaneko","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0385","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.0800973","article-title":"TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells","volume":"182","author":"Jiang","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103485_bb0390","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2741\/4279","article-title":"The role of invariant NKT cells in organ-specific autoimmunity","volume":"19","author":"Di Pietro","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0395","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-019-1991-y","article-title":"Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis","volume":"21","author":"Pecher","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cyto.2010.11.001","article-title":"Mechanism of regulation of autoimmunity by iNKT cells","volume":"53","author":"Novak","year":"2011","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0405","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0410","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nm0901-1057","article-title":"Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes","volume":"7","author":"Sharif","year":"2001","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.autrev.2023.103485_bb0415","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.190.7.963","article-title":"A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus","volume":"190","author":"Falcone","year":"1999","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0420","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/s41467-022-30759-w","article-title":"Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity","volume":"13","author":"Umeshappa","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2023.103485_bb0425","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2018.04.001","article-title":"iNKT cells ameliorate human autoimmunity: lessons from alopecia areata","volume":"91","author":"Ghraieb","year":"2018","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0430","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.immuni.2012.06.016","article-title":"Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production","volume":"37","author":"Lynch","year":"2012","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.autrev.2023.103485_bb0435","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1074\/jbc.M112.350066","article-title":"Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)\/STAT6 protein signaling axis in obesity","volume":"287","author":"Ji","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0440","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41467-018-02911-y","article-title":"CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells","volume":"9","author":"Oleinika","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0445","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1172\/JCI130670","article-title":"Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity","volume":"130","author":"Umeshappa","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0450","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41467-019-09893-5","article-title":"Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines","volume":"10","author":"Umeshappa","year":"2019","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.autrev.2023.103485_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108919","article-title":"Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP","volume":"34","author":"Umeshappa","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0460","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1034\/j.1600-0676.2003.00807.x","article-title":"Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis","volume":"23","author":"Harada","year":"2003","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0465","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2337\/db09-1116","article-title":"Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette","volume":"59","author":"Driver","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2220\/biomedres.35.161","article-title":"Increased activated natural killer T cells in the liver of patients with advanced stage primary biliary cirrhosis","volume":"35","author":"Aso-Ishimoto","year":"2014","journal-title":"Biomed Res"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0475","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0480","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0485","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/hep.510280303","article-title":"Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis","volume":"28","author":"Tsuneyama","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0490","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood.V98.4.1108","article-title":"Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface","volume":"98","author":"Hallermalm","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0495","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0161-5890(93)90008-Y","article-title":"Increased expression of MHC class I molecules on human cells after short time IFN-gamma treatment","volume":"30","author":"Vegh","year":"1993","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0500","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/JLB.2A0622-586RRRR","article-title":"IL-17A produced by invariant natural killer T cells and CD3(+) CD56(+) alphaGalcer-CD1d tetramer(\u2212) T cells promote liver fibrosis in patients with primary biliary cholangitis","volume":"112","author":"Jia","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0505","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0510","doi-asserted-by":"crossref","first-page":"G349","DOI":"10.1152\/ajpgi.00124.2017","article-title":"Establishment of a surgical bile duct injection technique giving direct access to the bile ducts for studies of the murine biliary tree","volume":"314","author":"Berntsen","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103485_bb0515","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.chom.2008.03.009","article-title":"Liver autoimmunity triggered by microbial activation of natural killer T cells","volume":"3","author":"Mattner","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0520","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1046\/j.1432-1327.2000.01189.x","article-title":"Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata","volume":"267","author":"Kawahara","year":"2000","journal-title":"Eur J Biochem"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2023.103485_bb0525","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.jim.2900708","article-title":"Chemical structure and function of glycosphingolipids of Sphingomonas spp and their distribution among members of the alpha-4 subclass of Proteobacteria","volume":"23","author":"Kawahara","year":"1999","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0530","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/immunohorizons.2000100","article-title":"Altered innate-like T cell development in Valpha14-Jalpha18 TCRalpha transgenic mice","volume":"4","author":"Lau","year":"2020","journal-title":"Immunohorizons"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0535","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cei.12224","article-title":"Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10\/Idd18) mice","volume":"175","author":"Wang","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0540","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.24113","article-title":"Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis","volume":"53","author":"Wu","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0545","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cei.12298","article-title":"Innate immunity drives xenobiotic-induced murine autoimmune cholangitis","volume":"177","author":"Chang","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0550","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2249.2012.04581.x","article-title":"The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis","volume":"168","author":"Shimoda","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0555","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaut.2018.09.009","article-title":"Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis","volume":"95","author":"Hsueh","year":"2018","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121320","article-title":"Innate immunity drives the initiation of a murine model of primary biliary cirrhosis","volume":"10","author":"Chang","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0565","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0570","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrgastro.2015.12","article-title":"Novel therapeutic targets in primary biliary cirrhosis","volume":"12","author":"Dyson","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0575","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103485_bb0580","doi-asserted-by":"crossref","first-page":"1035950","DOI":"10.3389\/fimmu.2022.1035950","article-title":"New insights into iNKT cells and their roles in liver diseases","volume":"13","author":"Gu","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103485_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103188","article-title":"Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis","volume":"19","author":"Tietz-Bogert","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0590","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.13541","article-title":"Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells","volume":"203","author":"Valestrand","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0595","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nm0901-1052","article-title":"The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice","volume":"7","author":"Hong","year":"2001","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.autrev.2023.103485_bb0600","doi-asserted-by":"crossref","first-page":"13838","DOI":"10.1073\/pnas.251531798","article-title":"Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets","volume":"98","author":"Naumov","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0605","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.194.12.1789","article-title":"Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis","volume":"194","author":"Jahng","year":"2001","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0610","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.11489","article-title":"Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide","volume":"50","author":"Chiba","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0615","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1002\/eji.200535235","article-title":"Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway","volume":"35","author":"Miellot","year":"2005","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0620","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-011-9590-y","article-title":"Brief treatment with iNKT cell ligand alpha-galactosylceramide confers a long-term protection against lupus","volume":"32","author":"Yang","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103485_bb0625","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fimmu.2018.00519","article-title":"Therapeutic potential of invariant natural killer T cells in autoimmunity","volume":"9","author":"Van Kaer","year":"2018","journal-title":"Front Immunol"},{"issue":"7501","key":"10.1016\/j.autrev.2023.103485_bb0630","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature13150","article-title":"Protective mucosal immunity mediated by epithelial CD1d and IL-10","volume":"509","author":"Olszak","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.autrev.2023.103485_bb0635","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nri2904","article-title":"Presumed guilty: natural killer T cell defects and human disease","volume":"11","author":"Berzins","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0640","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nri3725","article-title":"Natural killer T cells: drivers or passengers in preventing human disease?","volume":"14","author":"Berzins","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"10.1016\/j.autrev.2023.103485_bb0645","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.1833166100","article-title":"The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0650","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2015.06.025","article-title":"Tissue-specific distribution of iNKT cells impacts their cytokine response","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.autrev.2023.103485_bb0655","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.171.8.4020","article-title":"Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells","volume":"171","author":"Crowe","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103485_bb0660","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.4049\/jimmunol.181.10.6707","article-title":"Cutting edge: programmed death-1\/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy","volume":"181","author":"Chang","year":"2008","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103485_bb0665","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"Parekh","year":"2005","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0670","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4049\/jimmunol.1302623","article-title":"alpha-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2\/3","volume":"192","author":"Huang","year":"2014","journal-title":"J Immunol"},{"issue":"42","key":"10.1016\/j.autrev.2023.103485_bb0675","doi-asserted-by":"crossref","first-page":"17847","DOI":"10.1073\/pnas.0904078106","article-title":"Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1","volume":"106","author":"Kojo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.autrev.2023.103485_bb0680","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.194.3.313","article-title":"CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes","volume":"194","author":"Wang","year":"2001","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaut.2004.09.008","article-title":"Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice","volume":"23","author":"Mizuno","year":"2004","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.autrev.2023.103485_bb0690","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1084\/jem.194.12.1801","article-title":"Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis","volume":"194","author":"Singh","year":"2001","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.autrev.2023.103485_bb0695","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.4049\/jimmunol.173.6.3693","article-title":"Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids","volume":"173","author":"Parekh","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0700","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.4049\/jimmunol.179.4.2300","article-title":"A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner","volume":"179","author":"Coppieters","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103485_bb0705","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nnano.2017.56","article-title":"Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices","volume":"12","author":"Singha","year":"2017","journal-title":"Nat Nanotechnol"},{"issue":"7591","key":"10.1016\/j.autrev.2023.103485_bb0710","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103485_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101535","article-title":"Immunomodulatory and immunoregulatory nanomedicines for autoimmunity","volume":"56","author":"Montano","year":"2021","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0720","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nprot.2007.515","article-title":"Methods for detection, isolation and culture of mouse and human invariant NKT cells","volume":"3","author":"Watarai","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.autrev.2023.103485_bb0725","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fimmu.2018.00384","article-title":"Novel approaches to exploiting invariant NKT cells in cancer immunotherapy","volume":"9","author":"Wolf","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103485_bb0730","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.171.4.1775","article-title":"NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells","volume":"171","author":"Kenna","year":"2003","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103485_bb0735","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.humimm.2004.09.003","article-title":"The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients","volume":"65","author":"Konishi","year":"2004","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0740","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2012.01166.x","article-title":"Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells","volume":"250","author":"Girardi","year":"2012","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.autrev.2023.103485_bb0745","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imr.12322","article-title":"Activation of human T cells by CD1 and self-lipids","volume":"267","author":"de Jong","year":"2015","journal-title":"Immunol Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:30:47Z","timestamp":1761600647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1568997223002197"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103485","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103485"}}